The very low key announcement from OIL stated:
"Optiscan has been informed by CZM that the regulatory pathway is progressing as planned, with receipt of CE Mark for ZEISS CONVIVO® as the first step. Other countries are in preparation as per the planned roll-out strategy. "
Description of need for CE mark:
"Gain market access in Europe with CE mark approval. CE marking is the medical device manufacturer's claim that a product meets the essential requirements of all relevant European Medical Device Directives. The Directives outline the safety and performance requirements for medical devices in the European Union(EU)."
After all the R & D OIL has spent on this product (as well as Zeiss) I would have thought that at least a glowing press release would be in order...........and maybe a mention of the Münster Congress.
I also note that in the Zeiss announcement re the Congress that Convivo is described as FDA approval "pending". I have advised the new Executive Chairman of this but so far no additional announcement or addition to the OIL website.
OIL Price at posting:
6.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)